CoChat

Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals

Open access
Samanovic, Marie I., Cornelius, Amber R., Gray-Gaillard, Sophie L., Allen, Joseph Richard, Karmacharya, Trishala, Wilson, Jimmy P., Hyman, Sara Wesley, Tuen, Michael, Koralov, Sergei B., Mulligan, Mark J., Herati, Ramin Sedaghat · 2022 · Science Translational Medicine

Published version of a preprint

Cited by 117

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

The use of coronavirus disease 2019 (COVID-19) vaccines will play the major role in helping to end the pandemic that has killed millions worldwide. COVID-19 vaccines have resulted in robust humoral responses and protective efficacy in human trials, but efficacy trials excluded individuals with a prior diagnosis of COVID-19. As a result, little is known about how immune responses induced by mRNA vaccines differ in individuals who recovered from COVID-19. Here, we evaluated longitudinal immune responses to two-dose BNT162b2 mRNA vaccination in 15 adults who had experienced COVID-19, compared to 21 adults who did not have prior COVID-19. Consistent with prior studies of mRNA vaccines, we observed robust cytotoxic CD8 + T cell responses in both cohorts after the second dose. Furthermore, SARS-CoV-2–naive individuals had progressive increases in humoral and antigen-specific antibody-secreting cell (ASC) responses after each dose of vaccine, whereas SARS-CoV-2–experienced individuals demonstrated strong humoral and antigen-specific ASC responses to the first dose but these responses were not further enhanced after the second dose of the vaccine at the time points studied. Together, these data highlight the relevance of immunological history for understanding vaccine immune responses and may have implications for personalizing mRNA vaccination regimens used to prevent COVID-19, including for the deployment of booster shots.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.abi8961

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 34

  1. R. Tillett J. Sevinsky P. Hartley H. Kerwin N. Crawford A. Gorzalski C. Laverdure S. Verma C. Rossetto D. Jackson M. Farrell S. Van Hooser M. Pandori Genomic Evidence for a Case of Reinfection with SARS-CoV-2 (2020); 10.2139/ssrn.3680955. · DOI
  2. 10.1038/s41418-020-00720-9 · DOI · Paper page
  3. 10.1126/sciadv.abe8065 · DOI · Paper page
  4. 10.1016/j.immuni.2020.07.019 · DOI · Paper page
  5. 10.1038/s41586-020-2639-4 · doi:10.1038/s41586-020-2639-4 · Paper page
  6. A. B. Vogel, I. Kanevsky, Y. Che, K. A. Swanson, A. Muik, M. Vormehr, L. M. Kranz, K. C. Walzer, S. Hein, A. Güler, J. Loschko, M. S. Maddur, A. Ota-Setlik, K. Tompkins, J. Cole, B. G. Lui, T. Ziegenhals, A. Plaschke, D. Eisel, S. C. Dany, S. Fesser, S. Erbar, F. Bates, D. Schneider, B. Jesionek, B. Sänger, A.-K. Wallisch, Y. Feuchter, H. Junginger, S. A. Krumm, A. P. Heinen, P. Adams-Quack, J. Schlereth, S. Schille, C. Kröner, R. de la Caridad Güimil Garcia, T. Hiller, L. Fischer, R. S. Sellers, S. Choudhary, O. Gonzalez, F. Vascotto, M. R. Gutman, J. A. Fontenot, S. Hall-Ursone, K. Brasky, M. C. Griffor, S. Han, A. A. H. Su, J. A. Lees, N. L. Nedoma, E. H. Mashalidis, P. V. Sahasrabudhe, C. Y. Tan, D. Pavliakova, G. Singh, C. Fontes-Garfias, M. Pride, I. L. Scully, T. Ciolino, J. Obregon, M. Gazi, R. Carrion, K. J. Alfson, W. V. Kalina, D. Kaushal, P.-Y. Shi, T. Klamp, C. Rosenbaum, A. N. Kuhn, Ö. Türeci, P. R. Dormitzer, K. U. Jansen, U. Sahin, BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2. Cold Spring Harb. Protoc. , 2020.12.11.421008 (2020).
  7. 10.1056/NEJMoa2027906 · doi:10.1056/nejmoa2027906 · Paper page
  8. 10.1073/pnas.1409171111 · DOI · Paper page
  9. 10.1038/s41467-020-18465-x · DOI
  10. 10.1126/science.aai8128 · DOI · Paper page
  11. 10.1146/annurev-immunol-042617-053142 · DOI · Paper page
  12. 10.1016/j.vaccine.2008.10.087 · DOI · Paper page
  13. 10.2147/CIA.S25215 · DOI · Paper page
  14. 10.1001/jamainternmed.2020.5084 · DOI
  15. 10.4049/jimmunol.1600318 · DOI · Paper page
  16. 10.1016/j.immuni.2013.08.031 · DOI · Paper page
  17. 10.1126/scitranslmed.3005191 · DOI · Paper page
  18. 10.1038/srep26494 · DOI · Paper page
  19. 10.1126/sciimmunol.aai8153 · DOI · Paper page
  20. 10.1038/ni.3533 · DOI · Paper page
  21. 10.1073/pnas.1520112113 · DOI · Paper page
  22. 10.1038/s41586-021-03647-4 · DOI · Paper page
  23. 10.3389/fimmu.2018.02421 · DOI
  24. 10.1038/s41401-020-0485-4 · DOI · Paper page
  25. 10.1016/0022-1759(86)90268-1 · DOI · Paper page
  26. 10.1126/scitranslmed.3002336 · DOI · Paper page
  27. 10.1128/CDLI.5.6.799-803.1998 · DOI
  28. 10.1136/annrheumdis-2021-220597 · DOI · Paper page
  29. 10.1016/j.xcrm.2021.100262 · DOI
  30. 10.4049/jimmunol.2001381 · DOI
  31. A. Ellebedy, J. Turner, J. O’Halloran, E. Kalaidina, W. Kim, A. Schmitz, T. Lei, M. Thapa, R. Chen, J. Case, F. Amanat, A. Rauseo, A. Haile, M. Klebert, T. Suessen, W. Middleton, F. Krammer, S. Teefey, M. Diamond, R. Presti, X. Xie, P.-Y. Shi, SARS-CoV-2 mRNA vaccines induce a robust germinal centre reaction in humans. Nature Portfolio 10.21203/rs.3.rs-310773/v1 (2021). · DOI
  32. 10.1371/journal.ppat.1007634 · DOI
  33. 10.1093/bioinformatics/btp616 · DOI · Paper page
  34. 10.1016/S1473-3099(20)30483-7 · DOI · Paper page

Cited by

See all 117

Metadata

Authors
Samanovic, M. I., Cornelius, A. R., Gray-Gaillard, S. L., Allen, J. R., Karmacharya, T., Wilson, J. P., Hyman, S. W., Tuen, M., Koralov, S. B., Mulligan, M. J., & Herati, R. S.
Venue
Science Translational Medicine
Published
2022-02-09
Volume
14
Issue
631
Pages
eabi8961-eabi8961
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W4200629697
Cited by
117
References
45
FWCI
8.73
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.